Opendata, web and dolomites

Sensa

Effortlessly Diagnosing Sleep Apnea with the Sensa Platform

Total Cost €

0

EC-Contrib. €

0

Partnership

0

Views

0

 Sensa project word cloud

Explore the words cloud of the Sensa project. It provides you a very rough idea of what is the project "Sensa" about.

billion    gold    sufferers    diagnostics    pay    movements    considering    life    measuring    vast    expensive    diagnosing    consuming    polysomnography    multiplying    despite    mean    nor    pool    professional    medical    thereby    specialized    12    infrastructure    scalable    unidentified    experiences    diagnose    lower    diagnosed    founded    belgian    apnea    balance    screening    sense    total    savings    sensa    treatment    demand    person    neoma    device    exist    never    quantitative    companies    revenue    labs    standard    408    adults    regarding    49    fact    huge    obstructive    layer    connected    adds    affordable    pace    whilst    miniaturized    sleep    options    disease    serious    cardio    model    june    saved    patients    instrumentations    respiratory    qualitative    2015    health    team    people    time    million    market    diagnostic    solution    untreated    suffer    160    technologies    ill    day    osa    simplicity    experts    mandibular    consumers    medicine    reducing    burden    goes    validation    keep    undiagnosed    80    american    clinical   

Project "Sensa" data sheet

The following table provides information about the project.

Coordinator
SUNRISE 

Organization address
address: CHAUSSE DE MARCHE (EP) 569 BOITE 13
city: NAMUR
postcode: 5101
website: n.a.

contact info
title: n.a.
name: n.a.
surname: n.a.
function: n.a.
email: n.a.
telephone: n.a.
fax: n.a.

 Coordinator Country Belgium [BE]
 Project website http://neomalabs.com
 Total cost 71˙429 €
 EC max contribution 50˙000 € (70%)
 Programme 1. H2020-EU.3. (PRIORITY 'Societal challenges)
2. H2020-EU.2.3. (INDUSTRIAL LEADERSHIP - Innovation In SMEs)
3. H2020-EU.2.1. (INDUSTRIAL LEADERSHIP - Leadership in enabling and industrial technologies)
 Code Call H2020-SMEInst-2018-2020-1
 Funding Scheme SME-1
 Starting year 2018
 Duration (year-month-day) from 2018-04-01   to  2018-09-30

 Partnership

Take a look of project's partnership.

# participants  country  role  EC contrib. [€] 
1    SUNRISE BE (NAMUR) coordinator 50˙000.00

Map

 Project objective

12% of adults suffer from obstructive sleep apnea (OSA). Despite the fact that it is a serious disease, it goes undiagnosed 80% of the time. The cost of undiagnosed OSA patients is €6,000 per person per year whilst the cost of diagnosed patients is only €2,000 per person per year. Multiplying by around €4,000 that could be saved per diagnosed person, the total savings would be €160 billion/year. Very effective treatment options exist, but the traditional diagnostic infrastructure is neither affordable nor scalable to diagnose this vast number of unidentified sufferers. To this day, the polysomnography is the gold-standard for diagnosing OSA. However, this method is expensive, time-consuming and cannot keep pace with the huge demand. Neoma Labs has developed Sensa: a cost-effective, miniaturized and connected device that has the potential to become the new gold-standard in OSA diagnostic. The unique approach is measuring mandibular movements to assess OSA. The Sensa solution adds a qualitative layer to the quantitative measures, providing consumers with a sense of control over their health-life balance. The OSA diagnostics market is driven by a growing awareness regarding the ill effects of untreated sleep apnea, a large pool of undiagnosed OSA patients as well as emerging technologies. Regarding our revenue model, we are considering a pay-per-use model at €50/screening. With its simplicity and high clinical validation, Sensa will be able to help lower the 80% of OSA patients who go undiagnosed, thereby reducing the costs/burden associated with the disease. With around 408 million adults in the EU, this would mean 49 million people suffer from sleep apnea and 40 million never get diagnosed. Neoma Labs was founded in June 2015 by a team of experts with professional experience in the field of cardio-respiratory and sleep medicine (with previous experiences in Belgian and American companies, both specialized in the field of cardio-respiratory medical instrumentations.

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "SENSA" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an  email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "SENSA" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.3.;H2020-EU.2.3.;H2020-EU.2.1.)

Genetta (2019)

Pole climbing solution to improve safety at work and to prevent fatal accidents in industrial climbing

Read More  

MCBD (2019)

MCBD (MULTI-CORE BIOPSY DEVICE) INNOVATIVE BIOPSY TECHNOLOGY FOR THE NEW ERA OF TARGETED MEDICINE

Read More  

In-Heal (2019)

Standardised administration device for raw medical herbs

Read More